University of South Florida

St. Petersburg, Florida 33701-4899

1 studies enrolling now · 27 studies all time

What they study most

Anxiety Disorders in Youth With Autism, Asperger's Syndrome, and Pervasive Developmental Disorder Not Otherwise Specified, Asperger's Syndrome, Attention Deficit Hyperactivity Disorder (ADHD), Autism, Bipolar Depression, CVID, Common Variable Immune Deficiency, Common Variable Immunodeficiency, Generalized Anxiety Disorder, HIV Infections, Immune Thrombocytopenic Purpura (ITP), Mental Disorders

Studies at this site

• A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder — Running, not enrolling
• Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults — Completed
• Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder — Available (expanded access)
• A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases — Running, not enrolling
• A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases — Completed
• COVID-19 Vaccine Responses in PIDD Subjects — Running, not enrolling
• Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients — Stopped early
• Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
• Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
• Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD) — Completed
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder — Completed
• Pediatric Open-Label Extension Study — Completed
• Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency — Completed
• Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older — Stopped early
• D-cycloserine Augmentation of Cognitive Behavioral Therapy (CBT) for Pediatric Obsessive-compulsive Disorder (OCD) — Completed
• Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders — Completed
• A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) — Completed
• Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects — Completed
• Lurasidone Pediatric Autism Study — Completed
• Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder — Completed
• Cognitive Behavioral Therapy (CBT) for Anxiety Disorders in Autism: Adapting Treatment for Adolescents — Completed
• Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder — Completed
• Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder — Stopped early
• D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive Disorder — Completed
• Evaluation of Efficacy and Tolerability of Hizentra® — Status unconfirmed
• Evaluate Bacteriophage as a Useful Immunogen in Patients With Primary Immune Deficiency Diseases (PIDD) — Status unconfirmed
• Psychiatric Problems in Children and Adolescents Infected With HIV at Birth — Completed